Advanced Investment Partners’s Charles River Laboratories CRL Stock Holding History

Advanced Investment Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$50K	Buy	+1,090	New	+$46.7K	0.09%	182

Other funds holding CRL

PIM

Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Advanced Investment Partners's CRL Position: Q2 2013 in Review

Advanced Investment Partners opened a new position in Charles River Laboratories (CRL) in Q2 2013: 1,090 shares worth $50K. The stake represents 0.09% of the portfolio and ranks #182 among its holdings.

225 funds tracked by Wall St. Rank hold CRL as of Q2 2013.

Advanced Investment Partners held 1,090 shares of Charles River Laboratories worth $50K as of Q2 2013.
Charles River Laboratories was a new Advanced Investment Partners position in Q2 2013.
Charles River Laboratories made up 0.09% of Advanced Investment Partners's portfolio in Q2 2013, its #182 holding.
225 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2013.

Based on Advanced Investment Partners's 13F filing for Q2 2013, filed 16 Aug 2013.